Brief: Biora Therapeutics Announces Successful Completion Of Second Device Performance Study In Human Subjects For Its Targeted Therapeutics Platform
07/07/2022 14:36
July 7 (Reuters) - Biora Therapeutics Inc BIOR.O :
* BIORA THERAPEUTICS ANNOUNCES SUCCESSFUL COMPLETION OF
SECOND
DEVICE PERFORMANCE STUDY IN HUMAN SUBJECTS FOR ITS TARGETED
THERAPEUTICS PLATFORM
* BIORA THERAPEUTICS INC - NO DRUG WAS ADMINISTERED DURING
STUDY
* BIORA THERAPEUTICS INC - MORE INFORMATION ON PM-611 STUDY
WILL
BE RELEASED AS ANALYSIS IS COMPLETED AND SUBMITTED FOR
PUBLICATION
Source text for Eikon: ID:nGNX87BwGY
Further company coverage: BIOR.O
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules